quinazolines has been researched along with rotenone in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Katakura, K; Kido, Y; Kita, K; Matsumoto, J; Miyoshi, H; Nonaka, N; Oku, Y; Sakamoto, K; Shinjyo, N; Yagi, K; Yamamoto, N | 1 |
| Casida, JE; Rowlands, JC | 1 |
| Brandt, U; Lümmen, P; Okun, JG | 1 |
| Bernhardt, G; Buschauer, A; Gartner, M; Giannis, A; Gross, D; Müller, C; Sarli, V | 1 |
| Baba, Y; Fujii, M; Kato, Y; Maeda, T; Suzuki, A; Takada, S | 1 |
| Chen, S; Li, F; Liu, J; Shi, Y; Wang, Y; Wen, W | 1 |
6 other study(ies) available for quinazolines and rotenone
| Article | Year |
|---|---|
Anaerobic NADH-fumarate reductase system is predominant in the respiratory chain of Echinococcus multilocularis, providing a novel target for the chemotherapy of alveolar echinococcosis.
Topics: Anaerobiosis; Animals; Echinococcosis, Hepatic; Echinococcus multilocularis; Electron Transport; Enzyme Inhibitors; Mitochondria; Nitro Compounds; Oxidoreductases Acting on CH-CH Group Donors; Quinazolines; Rotenone; Thiazoles; Ubiquinone | 2008 |
NADH: ubiquinone oxidoreductase inhibitors block induction of ornithine decarboxylase activity in MCF-7 human breast cancer cells.
Topics: Breast Neoplasms; Electron Transport Complex I; Enzyme Induction; Epithelial Cells; Estradiol; Female; Humans; Insulin-Like Growth Factor I; NADH, NADPH Oxidoreductases; Ornithine Decarboxylase; Quinazolines; RNA, Messenger; Rotenone; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Uncoupling Agents | 1998 |
Three classes of inhibitors share a common binding domain in mitochondrial complex I (NADH:ubiquinone oxidoreductase).
Topics: Animals; Binding Sites; Cattle; Enzyme Inhibitors; Furans; Kinetics; Muscidae; NAD(P)H Dehydrogenase (Quinone); Pyridines; Pyrimidines; Quinazolines; Rotenone; Spectrometry, Fluorescence | 1999 |
Inhibitors of kinesin Eg5: antiproliferative activity of monastrol analogues against human glioblastoma cells.
Topics: Acridines; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cysteine; Dose-Response Relationship, Drug; Flow Cytometry; Fluoresceins; Glioblastoma; Humans; Insecticides; Kinesins; Molecular Structure; Paclitaxel; Pyrimidines; Quinazolines; Rotenone; Spindle Apparatus; Tetrahydroisoquinolines; Thiones; Time Factors; Tubulin; Tubulin Modulators; Vinblastine | 2007 |
Deguelin Potentiates Apoptotic Activity of an EGFR Tyrosine Kinase Inhibitor (AG1478) in PIK3CA-Mutated Head and Neck Squamous Cell Carcinoma.
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Class I Phosphatidylinositol 3-Kinases; Drug Synergism; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Head and Neck Neoplasms; Humans; Mutant Proteins; Mutation; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinase C; Protein Kinase Inhibitors; Quinazolines; Rotenone; Squamous Cell Carcinoma of Head and Neck; Time Factors; Tyrphostins | 2017 |
Discovery of evodiamine derivatives as potent insecticide candidates.
Topics: Animals; Calcium; Insecticides; Larva; Molecular Structure; Moths; Quinazolines; Rotenone; Ryanodine Receptor Calcium Release Channel | 2022 |